Cargando…

Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales

INTRODUCTION: England and Wales recently replaced the 7-valent pneumococcal conjugate vaccine (PCV7) with its 13-valent equivalent (PCV13), partly based on projections from mathematical models of the long-term impact of such a switch compared to ceasing pneumococcal conjugate vaccination altogether....

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yoon Hong, Jit, Mark, Flasche, Stefan, Gay, Nigel, Miller, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396640/ https://www.ncbi.nlm.nih.gov/pubmed/22808073 http://dx.doi.org/10.1371/journal.pone.0039927

Ejemplares similares

A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
por: Reglinski, Mark, et al.
Publicado: (2018)

From “Glivec(®)” to “Prevnar 13(®)”: How strong is the Indian drug patenting system?
por: Raj, Gerard Marshall
Publicado: (2018)

1432. County-Wide Pediatric IPD Experience Following Prevnar 13 Implementation
por: Nieves, Delma, et al.
Publicado: (2018)

Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010–2015)
por: Waye, Arianna, et al.
Publicado: (2015)

Prevnar 7 Childhood Immunization Program and Serotype Replacement: Changes in Pneumococcal Incidence and Resulting Impact on Health Care Costs in Alberta (2003–2008)
por: Waye, Arianna, et al.
Publicado: (2015)

Rapid kinetics of serum IgA after vaccination with Prevnar(®)13 followed by Pneumovax(®)23
por: Crowther, Rebecca R., et al.
Publicado: (2017)

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older
por: Buchwald, Ulrike K., et al.
Publicado: (2021)

Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
por: Szczepanek, Steven M., et al.
Publicado: (2016)

Impact of Prevnar vaccination on nasopharyngeal carriage of Streptococcus pneumoniae in healthy children in New Caledonia
por: Scotet, Julie, et al.
Publicado: (2011)

7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?
por: Choi, Yoon Hong, et al.
Publicado: (2011)

Booster immunization with a fractional dose of Prevnar 13 affects cell-mediated immune response but not humoral immunity in CD-1 mice
por: Catalioto, Rose-Marie, et al.
Publicado: (2021)

1184. A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)
por: Bili, Adroniki, et al.
Publicado: (2021)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2013)

Impact of COVID-19 social distancing measures on future incidence of invasive pneumococcal disease in England and Wales: a mathematical modelling study
por: Choi, Yoon Hong, et al.
Publicado: (2021)

Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study
por: Flasche, Stefan, et al.
Publicado: (2011)

Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study
por: Choi, Yoon Hong, et al.
Publicado: (2019)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Historical Population-Level Impact of Infant 13-Valent Pneumococcal Conjugate Vaccine (PCV13) National Immunization Programs on Invasive Pneumococcal Disease in Australia, Canada, England and Wales, Israel, and the United States
por: Perdrizet, Johnna, et al.
Publicado: (2023)

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
por: Oligbu, Godwin, et al.
Publicado: (2019)

Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study
por: Baguelin, Marc, et al.
Publicado: (2015)

Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
por: Makwana, Ashley, et al.
Publicado: (2018)

Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales
por: Andrews, Nick, et al.
Publicado: (2011)

Effectiveness of 23-Valent Polysaccharide Pneumococcal Vaccine and Changes in Invasive Pneumococcal Disease Incidence from 2000 to 2017 in Those Aged 65 and Over in England and Wales
por: Djennad, Abdelmajid, et al.
Publicado: (2019)

Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales
por: Chae, Chungman, et al.
Publicado: (2020)

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
por: Chen, Cynthia, et al.
Publicado: (2018)

Lunacy in England and Wales
Publicado: (1882)

Smallpox in England and Wales
Publicado: (1924)

Accelerating Control of Pertussis in England and Wales
por: Campbell, Helen, et al.
Publicado: (2012)

Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
por: Southern, Jo, et al.
Publicado: (2018)

Investigating the pertussis resurgence in England and Wales, and options for future control
por: Choi, Yoon Hong, et al.
Publicado: (2016)

The impact of COVID-19 vaccination in prisons in England and Wales: a metapopulation model
por: McCarthy, Ciara V., et al.
Publicado: (2022)

Coroners' records in England and Wales
por: Bowman, Marion
Publicado: (1990)

Hepatitis E in England and Wales
por: Lewis, Hannah C., et al.
Publicado: (2008)

The Prevalence of Lunacy in England and Wales
Publicado: (1902)

Condition of Lunacy in England and Wales
Publicado: (1876)

General Survey of England and Wales
por: Burnett, Napier
Publicado: (1920)

England, Wales and Scotland Awakening
Publicado: (1920)

Cancer mortality in 13 to 29-year-olds in England and Wales, 1981–2005
por: Geraci, M, et al.
Publicado: (2007)

Invasive Haemophilus influenzae Serotype e and f Disease, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2012)

Increased Invasive Pneumococcal Disease, North East England, UK
por: Houseman, Catherine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dfru62osan6eqe39mj1i3rpadj